435 related articles for article (PubMed ID: 19275709)
41. Synthesis, biological evaluation and docking study of a new series of di-substituted benzoxazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
Kaur A; Pathak DP; Sharma V; Wakode S
Bioorg Med Chem; 2018 Feb; 26(4):891-902. PubMed ID: 29373271
[TBL] [Abstract][Full Text] [Related]
42. Novel pyrazole derivatives as potential promising anti-inflammatory antimicrobial agents.
Bekhit AA; Ashour HM; Guemei AA
Arch Pharm (Weinheim); 2005 Apr; 338(4):167-74. PubMed ID: 15864786
[TBL] [Abstract][Full Text] [Related]
43. Synthesis, anti-inflammatory, ulcerogenic and cyclooxygenase activities of indenopyrimidine derivatives.
Undare SS; Valekar NJ; Patravale AA; Jamale DK; Vibhute SS; Walekar LS; Kolekar GB; Deshmukh MB; Anbhule PV
Bioorg Med Chem Lett; 2016 Feb; 26(3):814-818. PubMed ID: 26764192
[TBL] [Abstract][Full Text] [Related]
44. Synthesis, modeling and biological evaluation of some pyrazolo[3,4-d]pyrimidinones and pyrazolo[4,3-e][1,2,4]triazolo[4,3-a]pyrimidinones as anti-inflammatory agents.
Tageldin GN; Ibrahim TM; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM
Bioorg Chem; 2019 Sep; 90():102844. PubMed ID: 31229797
[TBL] [Abstract][Full Text] [Related]
45. Optimization of pyrazole-based compounds with 1,2,4-triazole-3-thiol moiety as selective COX-2 inhibitors cardioprotective drug candidates: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory, ulcerogenicity, cardiovascular evaluation, and molecular modeling studies.
Abdellatif KRA; Abdelall EKA; Elshemy HAH; Philoppes JN; Hassanein EHM; Kahk NM
Bioorg Chem; 2021 Sep; 114():105122. PubMed ID: 34243075
[TBL] [Abstract][Full Text] [Related]
46. New series of fused pyrazolopyridines: Synthesis, molecular modeling, antimicrobial, antiquorum-sensing and antitumor activities.
El-Gohary NS; Hawas SS; Gabr MT; Shaaban MI; El-Ashmawy MB
Bioorg Chem; 2019 Nov; 92():103109. PubMed ID: 31521987
[TBL] [Abstract][Full Text] [Related]
47. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1-phenylpyrazolo[3,4-d]pyrimidine derivatives.
Bakr RB; Azouz AA; Abdellatif KR
J Enzyme Inhib Med Chem; 2016; 31(sup2):6-12. PubMed ID: 27210522
[TBL] [Abstract][Full Text] [Related]
48. Synthesis of beta-hydroxypropanoic acid derivatives as potential anti-inflammatory, analgesic and antimicrobial agents.
Abdel-Rahman HM; Hussein MA
Arch Pharm (Weinheim); 2006 Jul; 339(7):378-87. PubMed ID: 16783838
[TBL] [Abstract][Full Text] [Related]
49. Synthesis of novel 1,3,4-trisubstituted pyrazoles as anti-inflammatory and analgesic agents.
Ragab FA; Abdel Gawad NM; Georgey HH; Said MF
Eur J Med Chem; 2013 May; 63():645-54. PubMed ID: 23567953
[TBL] [Abstract][Full Text] [Related]
50. COX-1/COX-2 inhibition assays and histopathological study of the new designed anti-inflammatory agent with a pyrazolopyrimidine core.
Abdelall EKA; Lamie PF; Ahmed AKM; El-Nahass ES
Bioorg Chem; 2019 May; 86():235-253. PubMed ID: 30716621
[TBL] [Abstract][Full Text] [Related]
51. Exploring Anti-inflammatory Potential of Thiazolidinone Derivatives of Benzenesulfonamide via Synthesis, Molecular Docking and Biological Evaluation.
Bari SB; Firake SD
Antiinflamm Antiallergy Agents Med Chem; 2016; 15(1):44-53. PubMed ID: 27216235
[TBL] [Abstract][Full Text] [Related]
52. Design, synthesis, and pharmacological evaluation of novel and selective COX-2 inhibitors based on celecoxib scaffold supported with in vivo anti-inflammatory activity, ulcerogenic liability, ADME profiling and docking study.
Abdellatif KRA; Abdelall EKA; Elshemy HAH; Philoppes JN; Hassanein EHM; Kahk NM
Bioorg Chem; 2022 Mar; 120():105627. PubMed ID: 35065465
[TBL] [Abstract][Full Text] [Related]
53. Dual evaluation of some novel 2-amino-substituted coumarinylthiazoles as anti-inflammatory-antimicrobial agents and their docking studies with COX-1/COX-2 active sites.
Chandak N; Kumar P; Kaushik P; Varshney P; Sharma C; Kaushik D; Jain S; Aneja KR; Sharma PK
J Enzyme Inhib Med Chem; 2014 Aug; 29(4):476-84. PubMed ID: 23777557
[TBL] [Abstract][Full Text] [Related]
54. New Coumarin Derivatives as Potent Selective COX-2 Inhibitors: Synthesis, Anti-Inflammatory, QSAR, and Molecular Modeling Studies.
Dawood DH; Batran RZ; Farghaly TA; Khedr MA; Abdulla MM
Arch Pharm (Weinheim); 2015 Dec; 348(12):875-88. PubMed ID: 26462142
[TBL] [Abstract][Full Text] [Related]
55. Synthesis, anti-inflammatory screening, molecular docking, and COX-1,2/-5-LOX inhibition profile of some novel quinoline derivatives.
Chaaban I; Rizk OH; Ibrahim TM; Henen SS; El-Khawass EM; Bayad AE; El-Ashmawy IM; Nematalla HA
Bioorg Chem; 2018 Aug; 78():220-235. PubMed ID: 29602046
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and evaluation of analgesic/ anti-inflammatory and antimicrobial activities of 3-substituted- 1,2,4-triazole-5-thiones.
Tozkoparan B; Küpeli E; Yeşilada E; Işik S; Ozalp M; Ertan M
Arzneimittelforschung; 2005; 55(9):533-40. PubMed ID: 16229118
[TBL] [Abstract][Full Text] [Related]
57. Synthesis, molecular docking, and pharmacological evaluation of N-(2-(3,5-dimethoxyphenyl)benzoxazole-5-yl)benzamide derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
Kaur A; Pathak DP; Sharma V; Wakode S
Arch Pharm (Weinheim); 2018 Jun; 351(6):e1800008. PubMed ID: 29741797
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and anti-inflammatory evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing an aminosulphonyl pharmacophore.
Abdellatif KR; Abdelgawad MA; Elshemy HA; Alsayed SS; Kamel G
Arch Pharm Res; 2015 Nov; 38(11):1932-42. PubMed ID: 25904239
[TBL] [Abstract][Full Text] [Related]
59. Design, synthesis and molecular modeling studies of new series of s-triazine derivatives as antimicrobial agents against multi-drug resistant clinical isolates.
Haiba NS; Khalil HH; Moniem MA; El-Wakil MH; Bekhit AA; Khattab SN
Bioorg Chem; 2019 Aug; 89():103013. PubMed ID: 31174040
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and in vitro-anticancer and antimicrobial evaluation of some novel quinoxalines derived from 3-phenylquinoxaline-2(1H)-thione.
El-Hawash SA; Wahab AE
Arch Pharm (Weinheim); 2006 Aug; 339(8):437-47. PubMed ID: 16881038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
